文献速递儿童青少年精神焦虑、强迫与应激相关障碍

自闭症谱系障碍儿童焦虑的认知行为治疗:一项随机临床试验

Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

这项随机临床试验纳入7-13岁自闭症谱系障碍(ASD)伴适应不良且干扰性焦虑的儿童,比较标准认知行为治疗(CBT)、为ASD改编的CBT与常规治疗(TAU)的疗效。结果显示,改编CBT在儿童焦虑评定量表上优于标准CBT和TAU,且两CBT组治疗应答率均高于TAU。结论认为CBT对ASD儿童焦虑有效,改编CBT具额外优势,建议临床医生发展CBT专长。

要点

  • 为ASD改编的CBT在改善焦虑上优于标准CBT和常规治疗。
  • 两种CBT的阳性治疗应答率均显著高于常规治疗。
  • 建议为学龄ASD儿童提供心理治疗的临床医生发展CBT专长。

核心结论

  • CBT对ASD伴干扰性焦虑的儿童有效,为ASD改编的CBT方法显示出额外优势。
  • 建议为学龄ASD儿童提供心理治疗的临床医生考虑发展CBT专长。

研究设计与样本

  • 随机临床试验于2014年4月开始在美国3个城市大学招募,至2017年1月收集数据。
  • 7-13岁ASD伴适应不良和干扰性焦虑的志愿者样本随机分配至标准CBT、ASD改编CBT或常规治疗,评估者设盲。
  • 初始入组214名儿童,167名随机化,145名完成治疗,22名停止参与。

主要发现

  • ASD改编CBT在家长报告的内化症状、ASD相关社交沟通症状及焦虑相关社会功能上均优于标准CBT和常规治疗。

关键数值与推荐

  • 主要结局为儿童焦虑评定量表(Pediatric Anxiety Rating Scale)。
  • 次要结局包括临床总体印象改善量表(Clinical Global Impressions-Improvement scale)的治疗应答和清单测量。

临床怎么用

  • 临床医生为学龄ASD儿童提供心理治疗时,可考虑采用CBT并发展相关专长。
  • 针对ASD的社交沟通和自我调节挑战,可整合观点采择训练和行为分析技术以增强CBT效果。

局限性

  • 未随机化的儿童因不符合入选标准(如确诊ASD)被排除。
  • 各条件间停止参与率无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Anxiety is common among youth with autism spectrum disorder (ASD), often interfering with adaptive functioning. Psychological therapies are commonly used to treat school-aged youth with ASD; their efficacy has not been established. OBJECTIVE: To compare the relative efficacy of 2 cognitive behavioral therapy (CBT) programs and treatment as usual (TAU) to assess treatment outcomes on maladaptive and interfering anxiety in children with ASD. The secondary objectives were to assess treatment outcomes on positive response, ASD symptom severity, and anxiety-associated adaptive functioning. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial began recruitment in April 2014 at 3 universities in US cities. A volunteer sample of children (7-13 years) with ASD and maladaptive and interfering anxiety was randomized to standard-of-practice CBT, CBT adapted for ASD, or TAU. Independent evaluators were blinded to groupings. Data were collected through January 2017 and analyzed from December 2018 to February 2019. INTERVENTIONS: The main features of standard-of-practice CBT were affect recognition, reappraisal, modeling/rehearsal, in vivo exposure tasks, and reinforcement. The CBT intervention adapted for ASD was similar but also addressed social communication and self-regulation challenges with perspective-taking training and behavior-analytic techniques. MAIN OUTCOMES AND MEASURES: The primary outcome measure per a priori hypotheses was the Pediatric Anxiety Rating Scale. Secondary outcomes included treatment response on the Clinical Global Impressions-Improvement scale and checklist measures. RESULTS: Of 214 children initially enrolled, 167 were randomized, 145 completed treatment, and 22 discontinued participation. Those who were not randomized failed to meet eligibility criteria (eg, confirmed ASD). There was no significant difference in discontinuation rates across conditions. Randomized children had a mean (SD) age of 9.9 (1.8) years; 34 were female (20.5%). The CBT program adapted for ASD outperformed standard-of-practice CBT (mean [SD] Pediatric Anxiety Rating Scale score, 2.13 [0.91] [95% CI, 1.91-2.36] vs 2.43 [0.70] [95% CI, 2.25-2.62]; P = .04) and TAU (2.93 [0.59] [95% CI, 2.63-3.22]; P < .001). The CBT adapted for ASD also outperformed standard-of-practice CBT and TAU on parent-reported scales of internalizing symptoms (estimated group mean differences: adapted vs standard-of-practice CBT, -0.097 [95% CI, -0.172 to -0.023], P = .01; adapted CBT vs TAU, -0.126 [95% CI, -0.243 to -0.010]; P = .04), ASD-associated social-communication symptoms (estimated group mean difference: adapted vs standard-of-practice CBT, -0.115 [95% CI, -0223 to -0.007]; P = .04; adapted CBT vs TAU: -0.235 [95% CI,-0.406 to -0.065]; P = .01); and anxiety-associated social functioning (estimated group mean difference: adapted vs standard-of-practice CBT, -0.160 [95% CI, -0.307 to -0.013]; P = .04; adapted CBT vs TAU: -0.284 [95% CI, -0.515 to -0.053]; P = .02). Both CBT conditions achieved higher rates of positive treatment response than TAU (BIACA, 61 of 66 [92.4%]; Coping Cat, 47 of 58 [81.0%]; TAU, 2 of 18 [11.1%]; P < .001 for each comparison). CONCLUSIONS AND RELEVANCE: In this study, CBT was efficacious for children with ASD and interfering anxiety, and an adapted CBT approach showed additional advantages. It is recommended that clinicians providing psychological treatments to school-aged children with ASD consider developing CBT expertise. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02028247.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Wood JJ, Kendall PC, Wood KS, et al. Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2020. PMID: 31755906. doi:10.1001/jamapsychiatry.2019.4160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。